Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient

Abstract

A 29-year-old male patient had severe atopic dermatitis (AD) and alopecia universalis (AU) that could not be controlled by using classic therapy. He started taking upadacitinib and achieved an excellent response for both his AD and AU. Thus, upadacitinib represents a promising therapeutic approach for patients with severe AD and alopecia areata.

Keywords

• Atopic dermatitis
• alopecia universalis
• upadacitinib
• eczema
• JAK inhibitor